Tianjin Key Laboratory of Cerebral Revascularization and Translational Innovation in Head and Neck Tumor Technologies

The Tianjin Key Laboratory of Cerebral Revascularization and Translational Innovation in Head and Neck Tumor Technologies was established on January 5, 2026, with the approval of the Tianjin Municipal Science and Technology Bureau. The laboratory is directed by Professor Tong Xiaoguang, Party Secretary and President of Tianjin Huanhu Hospital, Director of the Tianjin Institute of Neurosurgery, and a distinguished neurosurgeon. Professor Kang Chunsheng, Deputy Director of the Institute of Neurology and Director of the Neuro-Oncology Laboratory at Tianjin Medical University General Hospital, serves as Chair of the Academic Committee.

With a mission to advance the field through original technological innovation, the laboratory focuses on basic research, clinical diagnosis and treatment, and translational innovation in cerebral revascularization and head and neck tumors. It has developed and successfully implemented a number of innovative cerebral revascularization procedures and achieved technical breakthroughs in highly challenging operations, including posterior circulation bypass surgery. The laboratory has also pioneered and expanded hybrid surgical strategies for integrated treatment of cerebrovascular and cardiovascular diseases (“brain–heart integrated treatment”), as well as surgical revascularization techniques for acute large-vessel occlusion, providing advanced therapeutic options for highly complex and critically ill patients.

The Microsurgical Neuroanatomy Laboratory, drawing on the educational model of the Rhoton Laboratory in Florida, USA, has developed a distinctive “Tianjin Model” of microsurgical anatomy training that has subsequently been disseminated nationwide. In 2015, a Microsurgical Neurosurgery Laboratory was jointly established with Shenzhen People’s Hospital; in 2024, it was renamed the “Shenzhen Neurosurgical Technology Training and Innovation Center (Stanford University Subcenter, USA).” In 2016, a Microsurgical Neuroanatomy Laboratory was jointly established with Peking Union Medical College Hospital, and in 2025, a Head and Neck Surgical Anatomy Laboratory was established in collaboration with Tianjin Medical University. These training and collaborative platforms have trained more than 500 highly qualified scientific, technical, and academic professionals, substantially extending the reach and impact of advanced microsurgical technologies.

佟小光团队

头颈神经肿瘤中心团队

王红光团队

魏铭团队

闫华团队

The laboratory operates through an integrated PI-led team model and comprises five major research teams: the Tong Xiaoguang Team, focusing on cerebral revascularization; the Wang Hongguang Team, focusing on hybrid cerebrovascular treatment integrating cardiac and cerebral interventions; the Wang Hu Team, focusing on comprehensive management of head and neck neuro-oncological tumors; the Wei Ming Team, focusing on clinical cerebrovascular research; and the Yan Hua Team, focusing on basic research in physical therapies for tumors.

Each PI-led team independently conducts high-level clinical and basic research. Their findings have been published in leading international journals, including Science Advances, Advanced Science, and JAMA Network Open. Through collaborations with Capital Medical University and other academic institutions, research findings have also been published in internationally renowned medical journals such as The Lancet and JAMA.

Over the past 3 years, the laboratory has fostered one National Distinguished Physician (Professor Tong Xiaoguang), one National Outstanding Young Physician (Professor Wei Ming), and four members of Tianjin’s second cohort of high-level talents. The laboratory currently has seven doctoral supervisors. During this period, it has secured two national-level research grants and one provincial- or ministerial-level research grant, published 42 high-level research articles, and obtained six authorized invention patents.